Intranasal Insulin as Promising Therapy for Preserving Pragmatic Competence in MCI and AD
Reference74 articles.
1. Schatz S, González-Rivera M. Pragmatic function impairment and Alzheimer’s dementia. Pragmatics and Cognition. 2016;23:324-342
2. Schatz S, González-Rivera M. Executive functioning, visuo-spatial and inter-personal skill preservation in Alzheimer’s and mild cognitive impairment. In: Capone A, Carapezza M, Lo Piparo F, editors. Further Advances in Pragmatics and Philosophy: Part 2 Theories and Applications. Perspectives in Pragmatics, Philosophy and Psychology. Vol. 20. Cham: Springer; 2019. pp. 373-389
3. Schatz S, González-Rivera M. Intranasal insulin in Alzheimer’s disease: A pragmatic account. OBM Geriatrics. 2019;3(3):20. DOI: 10.21926/obm.geriatr.1903069
4. Akintola AA, van Heemst D. Insulin, aging, and the brain: Mechanisms and implications. Frontiers in Endocrinology. 2015;6:13. DOI: 10.3389/fendo.2015.00013
5. Hanson R, Frey WH. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neuroscience. 2008;9:S5